• Journal Article

Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases

Citation

Davis, K. L., Lenz, C., Houghton, K., & Kaye, J. A. (2017). Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases. International Journal of Radiation Oncology Biology Physics, 98(1), 239. DOI: 10.1016/j.ijrobp.2017.01.169

Abstract